Companies
Uniphar plots further M&A deals and reiterates medium-term target to hit €200m in profits
The listed healthcare group said it achieved steady growth in 2023 and is forecasting double-digit expansion of its new pharma division this year
Uniphar, the Irish listed healthcare services group, has reiterated its medium-term target to hit €200 million in annual profits as its pharma and medtech arms continue to see strong growth.
In a trading update issued to investors on Tuesday, Uniphar said it recorded organic profit growth “in excess of 5 per cent” last year, while Ebitda was in line with market expectations – implying full year earnings of around €115 million.
Listed on the Dublin ...
